Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.People who are genetically predisposed to produce lower amounts of a certain brain chemical that regulates appetite and stress may be at higher risk of severe depression, researchers said Monday.
The findings should shed more light on how depression affects certain people more than others, and could help lead the way toward developing more individualized therapies, researchers at the University of Michigan said.
"We've identified a biomarker - in this case genetic variation - that is linked with increased risk of major depression," said senior study author Jon-Kar Zubieta, a professor of psychiatry and radiology.
"This appears to be another mechanism, independent of previous targets in depression research, such as serotonin, dopamine and norepinephrine."
People who produce lower amounts of the brain molecule neuropeptide Y (NPY) had "measurably stronger brain responses to negative stimuli and psychological responses to physical pain," the study said.
"They were also overrepresented in a population diagnosed with a major depressive disorder."
The study, which appears in the Archives of General Psychiatry, used three different methods. First, researchers classified subject participants into three categories according to low, medium or high NPY expression.
Then, they used MRI (magnetic resonance imaging) to look at brain activity as the subjects viewed different words - some neutral (like "material"), some negative (like "murderer") and some positive (like "hopeful").
"In response to negative words, subjects in the low NPY group showed strong activation in the prefrontal cortex, which is involved with processing emotion, while subjects with high NPY demonstrated a much smaller response," the study said.
In the second trial, researchers looked at how subjects described their emotional state before and after a stress challenge in which saline solution was injected into their jaw muscles, causing moderate pain for about 20 minutes.
"Those in the low NPY group were more negative both before and after the pain - meaning they were more emotionally affected while anticipating the pain and while reflecting on their experience immediately afterward," it said.
Finally, researchers examined the NPY genotypes of people with major depressive disorders and found that, compared to a control group, people with low NPY were "overrepresented" in the group with depression.
"These are genetic features that can be measured in any person," said lead author Brian Mickey, an assistant professor in the Department of Psychiatry at the University of Michigan Medical School.
"We hope they can guide us toward assessing an individual's risk for developing depression and anxiety."
js/ksh/jm
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments